The frequency of hepatitis D virus in patients with hepatitis B in Iran: An increasing rate?

Tropical Doctor

Volumn 39, Issue 3, 2009, Pages 154-156

  Somi, Mohammad H ^a   Farhang, Sara ^a   Miri, Seyyed Mohammad ^a   Pouri, Ali A ^a   Mjidi, Golnar ^a   Alavian, Seyyed Moayed ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE; ARTICLE; BATTLE INJURY; BLOOD SAMPLING; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DENTAL CARE; EVALUATION; FEMALE; HEPATITIS B; HEPATITIS DELTA VIRUS; HOSPITAL PATIENT; HUMAN; INFECTION RATE; INTRAVENOUS DRUG ABUSE; IRAN; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEEDLESTICK INJURY; PREDICTOR VARIABLE; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; TATTOOING; TRAVEL;

CROSS-SECTIONAL STUDIES; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; IRAN; LOGISTIC MODELS; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

EID: 67650401482     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/td.2009.080365     Document Type: Article

References (10)

1. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatolog, 2006;43:S173-81
2. El Guneid AM, Gunaid AA, O'Neill AM, Zureikat NI, Coleman JC, Murray-Lyon IM. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol, 1993;40:330-3
3. Balik I, Onul M, Tekeli E, Caredda F. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. Eur J Epidemiol, 1991;7:48-54
4. Malekzadeh R, Borhanmanesh F. Prevalence and prognostic implications of hepatitis delta (D) virus infection in a asymptomatic hepatitis B surface antigen carriers in Iran. Ir J Med Sci, 1989;14:35-8
5. Alavian SM, Asari S, Manzori-Joybari H. Prevalence and risk factors of HDV infection in HBV infected cases. Govaresh, 2004; 9:217-21
6. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg, 1993;96:277-87
7. Hadziyannis SJ. Decreasing prevalence of hepatitis D virus infection. J Gastroenterol Hepatol, 1997;12:745-6
8. Hadziyannis SJ, Dourakis SP, Papaioannou C, Alexopoulou A, Hadziyannis ES, Gioustozi A. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res, 1993;382:259-66
9. Sagnelli E, Stroffolini T, Ascione A, et al., Decrease in HDV endemicity in Italy. J Hepatol, 1997;26:20-4
10. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med, 2002;34:207-14